Jasper Therapeutics Inc (JSPR)
23.67
+1.75
(+7.98%)
USD |
NASDAQ |
Apr 30, 16:00
23.67
0.00 (0.00%)
After-Hours: 16:32
Jasper Therapeutics Total Liabilities (Quarterly): 16.45M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.45M |
| September 30, 2023 | 16.27M |
| June 30, 2023 | 13.96M |
| March 31, 2023 | 13.56M |
| December 31, 2022 | 12.37M |
| September 30, 2022 | 11.54M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.58M |
| March 31, 2022 | 12.44M |
| December 31, 2021 | 24.14M |
| September 30, 2021 | 28.61M |
| December 31, 2020 | 58.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.54M
Minimum
Sep 2022
58.49M
Maximum
Dec 2020
19.95M
Average
13.96M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| Equillium Inc | 27.96M |
| Akero Therapeutics Inc | 44.96M |
| 89bio Inc | 59.96M |
| PepGen Inc | 34.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.89M |
| Shareholders Equity (Quarterly) | 78.44M |